A comprehensive review Author by Dr. George Johnson under Medicines fo Europe, "Review of Nitrosamine Drug Substance Related Impurities (NDSRI) in Pharmaceutical Drugs: Risk Assessment, Acceptable Intakes, and QSAR tools
I believe the point “LTL with Generic vs. Innovator companies” is an erratum?